Jan 15, 2020 / 06:00PM GMT
Ling Wang - JP Morgan Chase & Co, Research Division - Executive Director & Senior Greater China Healthcare Analyst
Yes, my name is Ling Wang. I'm one of the senior health care -- China health care analyst at JPMorgan, and welcome to our conference this year. The next presenting company is BeiGene, which is a leading biopharmaceutical company in China. The stock was dual listed on Nasdaq and also Hong Kong Stock Exchange. And presenting for the company is Mr. John Oyler, who is the Chief Executive Officer for the company.
So John, welcome, and thank you.
John V. Oyler - BeiGene, Ltd. - Co-Founder, Chairman & CEO
Hi, everyone. As said, I'm John Oyler. I'm the Chairman, Co-Founder, CEO of BeiGene. I'd really like to thank JPMorgan for having us at the conference this year. Thank you.
Before I get into the presentation, I have to remind you all the wonderful things, that we might be making forward-looking statements. Our business carries certain risks. Some of these are discussed in our filings with the SEC in Hong Kong. So please
Beigene Ltd at JPMorgan Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers